Cost-effectiveness of a potential future helicobacter pylori vaccine in the Netherlands; the impact of varying the discount rate for health

被引：0
|
作者：
Klok, R. M.
de Vries, R.
van der Zeijst, B.
Postma, M. J.
机构：
[1] Vaccine Inst, NL-3720 AL Bilthoven, Netherlands
[2] Univ Groningen, GUIDE, Dept Social Pharm Pharmacoepidemiol & Pharmacothe, NL-9713 AV Groningen, Netherlands
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2006年 / 62卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：726 / 726
页数：1
相关论文
共 50 条
  • [41] Economic and health impacts of Helicobacter pylori eradication strategy for the treatment of peptic ulcer disease: A cost-effectiveness analysis
    Kowada, Akiko
    Asaka, Masahiro
    HELICOBACTER, 2022, 27 (03)
  • [42] COST-EFFECTIVENESS OF HELICOBACTER-PYLORI (HELICOBACTER-PYLORI) ERADICATION IN THE LONG-TERM MANAGEMENT OF DUODENAL-ULCER
    OBRIEN, B
    GOEREE, R
    MOHAMED, AH
    HUNT, RH
    GASTROENTEROLOGY, 1995, 108 (04) : A27 - A27
  • [43] Future Directions for Cost-effectiveness Analyses in Health and Medicine
    Neumann, Peter J.
    Kim, David D.
    Trikalinos, Thomas A.
    Sculpher, Mark J.
    Salomon, Joshua A.
    Prosser, Lisa A.
    Owens, Douglas K.
    Meltzer, David O.
    Kuntz, Karen M.
    Krahn, Murray
    Feeny, David
    Basu, Anirban
    Russell, Louise B.
    Siegel, Joanna E.
    Ganiats, Theodore G.
    Sanders, Gillian D.
    MEDICAL DECISION MAKING, 2018, 38 (07) : 767 - 777
  • [44] Cost-effectiveness of a potential vaccine candidate for Haemophilus influenzae serotype 'a'
    Shoukat, Affan
    Van Exan, Robert
    Moghadas, Seyed M.
    VACCINE, 2018, 36 (12) : 1681 - 1688
  • [45] Potential cost-effectiveness of the nonavalent human papillomavirus (HPV) vaccine
    Drolet, Melanie
    Laprise, Jean-Francois
    Boily, Marie-Claude
    Franco, Eduardo L.
    Brisson, Marc
    INTERNATIONAL JOURNAL OF CANCER, 2014, 134 (09) : 2264 - 2268
  • [46] Potential Cost-Effectiveness of a Universal Influenza Vaccine in Older Adults
    France, Glenson
    Wateska, Angela R.
    Nowalk, Mary Patricia
    DePasse, Jay
    Raviotta, Jonathan M.
    Shim, Eunha
    Zimmerman, Richard K.
    Smith, Kenneth J.
    INNOVATION IN AGING, 2018, 2 (03)
  • [47] Potential Cost-Effectiveness of Pneumococcal Conjugate Vaccine (PCV) in Turkey
    Turel, Ozden
    Kisa, Adnan
    McIntosh, E. David G.
    Bakir, Mustafa
    VALUE IN HEALTH, 2013, 16 (05) : 755 - 759
  • [48] Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands
    Bos, JM
    Rümke, H
    Welte, R
    Postma, MJ
    CLINICAL THERAPEUTICS, 2003, 25 (10) : 2614 - 2630
  • [49] Cost-effectiveness of the varicella vaccine for administration to health care workers
    Burken, MI
    Roselle, GA
    JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 1997, 39 (07) : 605 - 607
  • [50] Cost-effectiveness analysis and effectiveness of pharmacist-managed outpatient clinics in Helicobacter pylori eradication therapy
    Seko, Takayuki
    Tachi, Tomoya
    Hatakeyama, Hiroo
    Noguchi, Yoshihiro
    Teramachi, Hitomi
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (06)
12345